Fri, 27 Feb 2026 | BUSINESS SALE
Vulcan Two Group plc, an AIM-listed cash shell focused on building an e-pharmacy group through acquisitions, has agreed deals to acquire a trio of businesses for a combined consideration of up to £41.7 million.
The buy-and-build group has agreed deals to acquire Yorkshire-headquartered CloudRx Holdings, Barnard Castle-based Hyperdrug Pharmaceuticals Ltd and Cheshire-based Webmed Pharmacy.
CloudRX is a digital prescription platform and fully regulated pharmacy that dispenses and distributes prescription medicines via a B2B2C platform. Vulcan Two Holdings will pay a maximum consideration of approximately £36 million for the business, of which around £32 million will be payable in cash on completion.
The Leeds-based company has 21 staff and three consultants working across roles such as pharmaceutical and customer service. Owner Daniel Lee will step down from his executive role with the business upon completion, but will remain on for a post-transition period.
Wedmed, a vertically integrated B2C digital pharmacy, was founded in 2014 to meet the need for discrete treatment and testing for sensitive conditions. The company dispenses and distributes medications through a bespoke consumer-facing eCommerce website. The consideration payable for the business is around £2.1 million.
Founded in 1985, Hyperdrug is a D2C digital pharmacy and online pet store that dispenses and distributes both human and veterinary medications, as well as providing an array of animal products and accessories. Vulcan Two Group will pay approximately £3.6 million for the company, comprising an initial consideration of around £3 million in cash and a total deferred cash consideration of around £600,000.
Michael Kraftman, Chief Executive of Vulcan Two, commented: “We are delighted to announce the acquisitions which will serve as the foundation on which we will aim to build the UK's leading regulated e-pharmacy platform.”
“This significant milestone marks the beginning of an exciting new chapter as we work to integrate the targets and pursue our strategy as stated at IPO, supported by strong market tailwinds. We believe we are well positioned for the future, and look forward with great excitement to further opportunities ahead."
Vulcan Two Group was admitted to trading on AIM in September 2025, with a mandate to acquire businesses in the UK e-pharmacy space. The group is led by Chief Executive Michael Kraftman and COO Brendan O’Brien.
Kraftman and O’Brien have significant experience in the e-commerce healthcare market, having built leading online contact lens supplier Vision Direct between 2009 and 2021, utilising a mix of organic growth and acquisitions.
Find out more about M&A trends in the UK's healthcare sector
Integration should be the highest priority for businesses operating buy-and-build strategies
This well-established retail pharmacy boasts a prime location near multiple medical practitioners, ensuring exceptional footfall and customer exclusivity.
Discover an exceptional opportunity to own a thriving dental practice in Gloucestershire, featuring eight state-of-the-art surgeries spread across two well-positioned locations.
Opportunity to acquire a well-established social care company in County Durham, featuring eight owned supported living properties and solid contracts with local authorities.
LEASEHOLD
Please choose your settings for this site below. For more information please read our Cookie Policy
These cookies are necessary for our website to function properly and provide you with access to all features.
These are analytics cookies that help us to improve the way our website works.
These are used to improve the functional performance of the website and make it easier for you to use.